Search

Your search keyword '"Edelstein, DL"' showing total 20 results

Search Constraints

Start Over You searched for: Author "Edelstein, DL" Remove constraint Author: "Edelstein, DL"
20 results on '"Edelstein, DL"'

Search Results

1. Abstract P4-01-16: Detection of plasma tumor DNA (ptDNA) in patients with hormone receptor-positive HER2-negative (HR+HER2-) early breast cancer (EBC) in clinical remission

2. Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing

3. Budget Impact Analysis of Circulating Tumor DNA Testing for Colon Cancer in Commercial Health and Medicare Advantage Plans.

4. Next-generation sequencing (NGS) profiling of matched tumor and circulating tumor DNA (ctDNA) in head and neck squamous cell carcinoma (HNSCC).

5. Prospective study evaluating dynamic changes of cell-free HPV DNA in locoregional viral-associated oropharyngeal cancer treated with induction chemotherapy and response-adaptive treatment.

6. Secondary resistance to anti-EGFR therapy by transcriptional reprogramming in patient-derived colorectal cancer models.

7. Routine Molecular Screening of Patients with Advanced Non-SmallCell Lung Cancer in Circulating Cell-Free DNA at Diagnosis and During Progression Using OncoBEAM TM EGFR V2 and NGS Technologies.

8. Expanded Low Allele Frequency RAS and BRAF V600E Testing in Metastatic Colorectal Cancer as Predictive Biomarkers for Cetuximab in the Randomized CO.17 Trial.

9. Blood-based RAS mutation testing: concordance with tissue-based RAS testing and mutational changes on progression.

10. Profiling of circulating tumor DNA in plasma of non-small cell lung cancer patients, monitoring of epidermal growth factor receptor p.T790M mutated allelic fraction using beads, emulsion, amplification, and magnetics companion assay and evaluation in future application in mimicking circulating tumor cells.

11. From validity to clinical utility: the influence of circulating tumor DNA on melanoma patient management in a real-world setting.

12. Cross-platform comparison for the detection of RAS mutations in cfDNA (ddPCR Biorad detection assay, BEAMing assay, and NGS strategy).

13. Blood-based detection of RAS mutations to guide anti-EGFR therapy in colorectal cancer patients: concordance of results from circulating tumor DNA and tissue-based RAS testing.

14. Risk of Colorectal and Other Cancers in Patients With Serrated Polyposis.

15. Serrated polyposis: rapid and relentless development of colorectal neoplasia.

16. Detection of familial adenomatous polyposis with orthogonal polarized spectroscopy of the oral mucosa vasculature.

17. A new phenotypic manifestation of familial adenomatous polyposis.

18. Detection of tumor DNA at the margins of colorectal cancer liver metastasis.

19. Rapid development of colorectal neoplasia in patients with Lynch syndrome.

20. Occurrence of colorectal adenomas in younger adults: an epidemiologic necropsy study.

Catalog

Books, media, physical & digital resources